The 24th John Goldman Conference on Chronic Myeloid Leukemia (CML): Biology and Therapy took place on October 21-23, 2022 in Mandelieu-La Napoule, France, and saw leading experts in CML from around the globe come together to discuss the latest advances in our understanding of the biology of CML, as well as the latest updates in treatments for this hematological malignancy.
View all videos

ESH CML 2022

The 24th Annual John Goldman Conference on Chronic Myeloid Leukemia: Biology and Therapy
21–23 October 2022 | Mandelieu-La Napoule, France

Claudio Cerchione (@DottorClaudio) discusses the importance of gene expression profiling and molecular testing in multiple myeloma:

👉http://ow.ly/WnjW50LM94U👈

@sohoitaly #SOHOItaly2022 #MMsm #HemOnc

The CONCEPT trial is a good proof of concept on how to improve the outcome of high risk myeloma #ASH22 ⁦@COMyCongress⁩ ⁦@TheIACH⁩ ⁦@Mohty_EBMT⁩

We're hosting a Post-ASH Virtual Workshop Series, featuring presentations & discussions on selected abstracts from the 64th #ASH22 Annual Meeting💻🩸

Register for the #ALL session with Elias Jabbour, Sabina Chiaretti, Daniel DeAngelo & @LuskinMarlise👉 http://bit.ly/3XI9HVN

NEW VJSocial Masterclass coming this week all about Social Media Strategy📱

@doctorpemm, @mpdrc & @harrisoncn1 share their own tips & advice on building a social media strategy alongside your clinical practice💡

Check out our previous Masterclass here: http://bit.ly/3UfLxiq

#ESHCML2022 | Toshio Kitamura comments on the impact of BCR-ABL mutations on signaling pathway activation in patients with CML.

Watch his interview here:

🎥: http://ow.ly/aiRv50LM8Rq

@ESHaematology #LeuSM #HemOnc #CMLsm

Load More...

ESH CML 2022

The 24th Annual John Goldman Conference on Chronic Myeloid Leukemia: Biology and Therapy
21–23 October 2022 | Mandelieu-La Napoule, France
The 24th John Goldman Conference on Chronic Myeloid Leukemia (CML): Biology and Therapy took place on October 21-23, 2022 in Mandelieu-La Napoule, France, and saw leading experts in CML from around the globe come together to discuss the latest advances in our understanding of the biology of CML, as well as the latest updates in treatments for this hematological malignancy.
View all videos

Claudio Cerchione (@DottorClaudio) discusses the importance of gene expression profiling and molecular testing in multiple myeloma:

👉http://ow.ly/WnjW50LM94U👈

@sohoitaly #SOHOItaly2022 #MMsm #HemOnc

The CONCEPT trial is a good proof of concept on how to improve the outcome of high risk myeloma #ASH22 ⁦@COMyCongress⁩ ⁦@TheIACH⁩ ⁦@Mohty_EBMT⁩

We're hosting a Post-ASH Virtual Workshop Series, featuring presentations & discussions on selected abstracts from the 64th #ASH22 Annual Meeting💻🩸

Register for the #ALL session with Elias Jabbour, Sabina Chiaretti, Daniel DeAngelo & @LuskinMarlise👉 http://bit.ly/3XI9HVN

NEW VJSocial Masterclass coming this week all about Social Media Strategy📱

@doctorpemm, @mpdrc & @harrisoncn1 share their own tips & advice on building a social media strategy alongside your clinical practice💡

Check out our previous Masterclass here: http://bit.ly/3UfLxiq

#ESHCML2022 | Toshio Kitamura comments on the impact of BCR-ABL mutations on signaling pathway activation in patients with CML.

Watch his interview here:

🎥: http://ow.ly/aiRv50LM8Rq

@ESHaematology #LeuSM #HemOnc #CMLsm

Load More...

Sign-up for our Newsletter!

Keep up to date with all the latest news with our monthly newsletter